Rbf Capital, LLC Immucell Corp Transaction History

Rbf Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$5.98 - $11.88 $78,254 - $155,461	-13,086 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$5.21 - $6.42 $68,178 - $84,012	13,086 New	13,086 $78,000
Q4 2020 Feb 11, 2021	SELL	$5.21 - $6.42 $68,178 - $84,012	-13,086 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.98 - $6.35 $65,168 - $83,096	13,086 New	13,086 $71,000
Q3 2020 Nov 16, 2020	SELL	$4.98 - $6.35 $65,168 - $83,096	-13,086 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$3.95 - $4.9 $51,689 - $64,121	13,086 New	13,086 $62,000
Q1 2020 May 18, 2020	SELL	$3.79 - $5.92 $49,595 - $77,469	-13,086 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$6.74 - $9.23 $88,199 - $120,783	13,086	13,086 $115,000

1.15M

Ticker ICCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,746,860
Market Cap $30.2M
Description
ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive ...

Get notified when there are updates to the investment portfolio of Rbf Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Rbf Capital, LLC with notifications on news.